Guerbet has announced that as of 1 February 2017, Methapharm will promote and distribute all Guerbet products in Canada.
“As a result of our excellent experience with Methapharm over the past four years, we have expanded the range of Guerbet products in their care for promotion and distribution,” says Massimo Carrara, vice president North America, Guerbet. “We are confident that our successful partnership with Methapharm will continue to flourish with this expanded product line.”
Guerbet is committed to partnering with local associates to support Canadian patients and practitioners and to fostering local production in Canada at its Guerbet fill and finish plant in Montreal.
Guerbet solutions distributed by Methapharm will now span the full range of the company’s products registered in Canada. This includes contrast media products (including Lipiodol, Patent Blue V, OptiRay, Conray and Telebrix); injectors and consumables.
With these developments, Guerbet continues to extend its footprint in North America. Guerbet previously solidified its position as a global leader with the acquisition of US-based Mallinckrodt’s Contrast Media and Delivery Systems (CMDS) business in 2015.